Table 2

Average value for each outcome measure for profiles designated as minimal disease activity by different levels of agreement by respondents

TJCSJCPASIBSAPain VASGlobal VASHAQEnthesitis
>70% agreement (n = 13)
Mean (SD)0.46 (0.88)0.31 (0.48)0.55 (0.70)2.08 (2.93)14.3 (8.53)23.5 (23.0)0.36 (0.31)0.46 (1.66)
95% CI−0.07 to 0.990.02 to 0.600.13 to 0.980.31 to 3.859.11 to 19.49.57 to 37.40.17 to 0.54−0.54 to 1.47
Min, max0, 30, 10, 1.70, 80, 280, 870, 1.130, 6
>80% agreement (n = 10)
Mean (SD)0.10 (0.32)0.10 (0.32)0.46 (0.69)1.60 (2.76)14.9 (9.60)25.7 (25.8)0.40 (0.34)0 (0)
95% CI−0.13 to 0.33−0.13 to 0.33−0.03 to 0.95−0.37 to 3.578.04 to 21.87.27 to 44.10.16 to 0.64N/A
Min, max0, 10, 10, 1.70, 80, 280, 870, 1.130, 0
>90% agreement (n = 7)
Mean (SD)0 (0)0 (0)0.41 (0.61)2.00 (3.21)11.1 (8.41)14.6 (13.0)0.29 (0.26)0 (0)
95% CIN/AN/A−0.15 to 0.98−0.97 to 4.973.29 to 18.92.55 to 26.60.05 to 0.52N/A
Min, max0, 00, 00, 1.30, 80, 200, 390, 0.750, 0
  • BSA, body surface area; HAQ, health assessment questionnaire; PASI, Psoriasis Activity and Severity Index; SJC, swollen joint count; TJC, tender joint count; VAS, visual analogue scale.